Replies to post #452623 on Anavex Life Sciences Corp (AVXL)

[plexrec]

CM--"I think this is a new write"--I agree --recent new write-up--very bullish !!!!

[kund]

Another useless article, looks like Mayo getting ready for his fund raising event. This POS will be in penny land soon, very soon and it is around the corner, it is on target when it gets there.

[georgejjl]

Summary
Anavex's full Alzheimer's 2b/3 data is set to be published in a peer-reviewed journal soon.

The company is likely positioned for Alzheimer's approval in Europe.

We expect benefit of Blarcamesine over mAbs in cost, safety, administration, and efficacy will allow it to explosively supersede the antibodies in market penetration.

A phase 2 Schizophrenia trial testing Anavex 3-71 is imminent.

Further Rett Syndrome guidance is expected in 2024 which may result in approval.

Further, more in-depth analysis can be found in the 2022 and 2023 archive folders.

https://www.sotcanalytics.com/home

Good luck and GOD bless,

[sage4]

Thank you. Many thanks to MayoMobile,too.
Maybe he can put his works on SA for more exposure.